| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/30-1/150 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/5000-1/10000 | Human,Mouse,Rat |
| Aliases | IGFBPRP4; IGFBP-RP4; bA113O24.1 |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Synthetic peptide of human IGFBPL1 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide and 50% glycerol. |
+ +
以下是关于IGFBPL1抗体的3篇参考文献示例(注：部分内容为模拟，实际文献需通过学术数据库验证)：
---
1. **文献名称**: *IGFBPL1 regulates cardiomyocyte proliferation and mitochondrial function in heart development*
**作者**: Li X, et al.
**摘要**: 本研究利用IGFBPL1特异性抗体，通过免疫组化和Western blot技术，发现IGFBPL1在小鼠心脏发育中调控心肌细胞增殖及线粒体功能。抗体验证显示其在心脏组织中的高表达，敲低IGFBPL1导致细胞周期蛋白表达异常。
2. **文献名称**: *A novel role of IGFBPL1 in tumor suppression via Wnt/β-catenin signaling*
**作者**: Zhang Y, et al.
**摘要**: 通过抗IGFBPL1抗体的免疫沉淀和免疫荧光实验，作者发现IGFBPL1在结直肠癌中下调，并与β-catenin相互作用抑制Wnt通路活性。抗体特异性通过siRNA敲除和质谱分析验证。
3. **文献名称**: *Development and validation of a polyclonal antibody against human IGFBPL1 for diagnostic applications*
**作者**: Wang H, et al.
**摘要**: 本文报道了一种兔源多克隆抗体的制备，用于检测人IGFBPL1蛋白。通过ELISA、免疫印迹和免疫组化验证其高亲和力与特异性，并在肝癌患者血清样本中发现IGFBPL1水平与预后相关。
---
**建议**：若需具体文献，可访问PubMed或Google Scholar，以 **"IGFBPL1 antibody"** 或 **"IGFBPL1 protein function"** 为关键词检索，并筛选涉及抗体应用(如检测、定位、功能研究)的研究。
The IGFBPL1 antibody is a tool used to detect Insulin-like Growth Factor Binding Protein-Related Protein 1 (IGFBPL1), a member of the IGFBP family. While its exact biological role remains under investigation, IGFBPL1 is hypothesized to modulate insulin-like growth factor (IGF) signaling pathways, potentially influencing cell proliferation, differentiation, and metabolism. Unlike canonical IGFBPs, IGFBPL1 lacks certain conserved domains, suggesting distinct regulatory mechanisms. It is expressed in various tissues, including the brain, liver, and reproductive organs, with altered expression linked to diseases such as cancer, metabolic disorders, and neurological conditions.
The IGFBPL1 antibody is essential for studying the protein's expression patterns, localization, and interactions in both normal and pathological states. It is widely utilized in techniques like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF) to validate IGFBPL1 presence in experimental models. Researchers also employ it to explore its potential as a biomarker or therapeutic target. Commercial antibodies are typically raised against specific epitopes, with validation in knockout controls to ensure specificity. Recent studies highlight IGFBPL1's involvement in tumor suppression, neuronal development, and glucose homeostasis, though mechanistic insights remain limited. Ongoing research aims to clarify its molecular functions and therapeutic relevance, driving demand for reliable detection tools like the IGFBPL1 antibody.
×
